reference/26923913

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/26923913

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase IV\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	1624
issn	0149-2918
issueIdentifier	7
pageRange	1613-1624
publicationName	Clinical Therapeutics
startingPage	1613
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5d012cfae6e8b67d8437e7145ea9a68f
bibliographicCitation	Zhu DL, Bays H, Gao P, Mattheus M, Voelker B, Ruilope LM. Efficacy and tolerability of initial therapy with single-pill combination telmisartan/hydrochlorothiazide 80/25 mg in patients with grade 2 or 3 hypertension: a multinational, randomized, double-blind, active-controlled trial. Clin Ther. 2012 Jul;34(7):1613–24. doi: 10.1016/j.clinthera.2012.05.007. PMID: 22717420.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4e66beaa9c9f1104d3c332024efd412 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a93d47f0667f2ab86a65ef6f83fe77c5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_09d8298175ea1cafc28c326737884241 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_61f4f71a923c258e43162d840301498c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cabf978bcb36abfb4eeabe3cb7078662 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eabd4c6b40df9d82a3e8a96e64657cf6
date	201207
identifier	https://doi.org/10.1016/j.clinthera.2012.05.007 https://pubmed.ncbi.nlm.nih.gov/22717420
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2822 https://portal.issn.org/resource/ISSN/0149-2918
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Efficacy and Tolerability of Initial Therapy With Single-Pill Combination Telmisartan/Hydrochlorothiazide 80/25 mg in Patients With Grade 2 or 3 Hypertension: A Multinational, Randomized, Double-Blind, Active-Controlled Trial
discusses	http://id.nlm.nih.gov/mesh/M0002350 http://id.nlm.nih.gov/mesh/M0002348 http://id.nlm.nih.gov/mesh/M0010703 http://id.nlm.nih.gov/mesh/M0223750 http://id.nlm.nih.gov/mesh/M0001456 http://id.nlm.nih.gov/mesh/M0006823 http://id.nlm.nih.gov/mesh/M0456879 http://id.nlm.nih.gov/mesh/M0400843
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D006852Q000627 http://id.nlm.nih.gov/mesh/D000959Q000627 http://id.nlm.nih.gov/mesh/D001565Q000627 http://id.nlm.nih.gov/mesh/D006973Q000188 http://id.nlm.nih.gov/mesh/D001562Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006973Q000503 http://id.nlm.nih.gov/mesh/D006852Q000008 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D006852Q000009 http://id.nlm.nih.gov/mesh/D047228Q000627 http://id.nlm.nih.gov/mesh/D001565Q000008 http://id.nlm.nih.gov/mesh/D012720 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D001794Q000187 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D047228Q000009 http://id.nlm.nih.gov/mesh/D047228Q000008 http://id.nlm.nih.gov/mesh/D004338 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D001565Q000009 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D000077333 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000959Q000009 http://id.nlm.nih.gov/mesh/D000959Q000008 http://id.nlm.nih.gov/mesh/D001562Q000009 http://id.nlm.nih.gov/mesh/D001562Q000008
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216293 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65999

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129150717

Total number of triples: 65.